Chemical Compound

LEVOMENOL

CAS Registry Number 23089-26-1
LEVOMENOL chemical structure
Primary Record

LEVOMENOL

In stock
951 g
Purity
99.5 %
CAS
23089-26-1

Compound Identifiers & Properties

CAS
23089-26-1
PubChem CID
442343
SMILES
CC1=CC[C@H](CC1)[C@](C)(CCC=C(C)C)O
Canonical SMILES
CC(C)=CCC[C@](C)(O)[C@@H]1CC=C(C)CC1

Names & Synonyms

  • LEVOMENOL
  • (-)-alpha-Bisabolol
  • alpha-Bisabolol
  • Bisabolol
  • Kamillosan
  • Levomenolum
  • Kamilosan
  • alpha-(-)-Bisabolol
  • 23089-26-1
  • .alpha.-Bisabolol
  • 1-alpha-Bisabolol
  • Dragosantol
  • Levomenol [INN]
  • Bisbalol
  • Camilol
  • a-Bisabolol
  • alpha-Bisabolol, L-
  • Hydagen B
  • Natural Bisabolol
  • (-)-|A-Bisabolol
  • Levomenol, INN
  • L-alpha-Bisabolol
  • (-)-a-Bisabolol
  • l-.alpha.-Bisabolol
  • Levomenol (Standard)
  • (-)-?-Bisabolol
  • alpha-Bisabolol (-)-form
  • (?)-|A-Bisabolol
  • (-)-.alpha.-Bisabolol
  • Levomenolum [INN-Latin]
  • UNII-24WE03BX2T
  • -ALPHA-BISABOLOL
  • BISABOLOL, ALPHA
  • PurpleU BAOBAB FACE
  • Dragosantol (>80%)
  • RefChem:40862
  • Bisabolol, (-)-.alpha.
  • .alpha.-Bisabolol, L-
  • AC1L9CMZ
  • (-)- alpha -Bisabolol
  • .alpha.-(-)-Bisabolol
  • .alpha.-bisabolol, (-)-
  • 24WE03BX2T
  • BISABOLOL [VANDF]
  • CCRIS 9081
  • Levomenolum (INN-Latin)
  • DTXSID4042094
  • .alpha.-Bisabolol (-)-form
  • LEVOMENOL (MART.)
  • LEVOMENOL [MART.]
  • (-)--BISABOLOL
  • ALPHA-(-)BISABOLOL
  • BISABOLOL, .ALPHA.
  • LEVOMENOL (USP-RS)
  • LEVOMENOL [USP-RS]
  • LEVOMENOL [WHO-DD]
  • BISABOLOL, (-)-alpha
  • RGZSQWQPBWRIAQ-CABCVRRESA-N
  • UNII-36HQN158VC
  • SCHEMBL24989
  • DTXCID2022094
  • FEMA NO. 4666
  • RACEMIC ALFA-BISABOLOL
  • alpha-BISABOLOL, (-)-
  • CHEBI:125
  • Levomenol; (-)-a-Bisabolol
  • C15H26O
  • EINECS 245-423-3
  • MFCD03412455
  • orb1685377
  • (.alpha.s,1s)-.alpha.-bisabolol
  • (alphaS,1S)-alpha-BISABOLOL
  • CHEMBL1096927
  • HY-N6967R
  • 3-CYCLOHEXENE-1-METHANOL
  • (-)-(4S,8S)-alpha-Bisabolol
  • (-)-alpha-Bisabolol (Levomenol)
  • GLXC-20390
  • HY-N6967
  • ZINC1849759
  • [S-(R*,R*)]-.alpha.-Bisabolol
  • BISABOLA-1,12-DIEN-8-OL
  • EINECS 208-205-9
  • EINECS 246-973-7
  • Tox21_301375
  • BDBM50382730
  • C15-H26-O
  • CID442343
  • EBC-26234
  • NSC782530
  • (2S)-6-methyl-2-[(1S)-4-methylcyclohex-3-en-1-yl]hept-5-en-2-ol
  • Levomenol 100 microg/mL in Methanol
  • DB13153
  • FB75117
  • LMPR0103060001
  • NSC-782530
  • (-)-alpha-Bisabolol, >=93% (GC)
  • (-)-6-Methyl-2-(4-methyl-3-cyclohexen-1-yl)-5-hepten-2-ol
  • (-)-Alpha-bisabolol(-)-alpha-bisabolol
  • NCGC00255987-01
  • (-)-alpha-Bisabolol, analytical standard
  • DA-74979
  • J38.588C
  • TS-09816
  • .ALPHA.-BISABOLOL (-)-FORM [MI]
  • CAS-23089-26-1
  • ?-Bisabolol 1000 microg/mL in Isopropanol
  • 3-Cyclohexene-1-methanol, a,4-dimethyl-a-(4-methyl-3-pentenyl)-,(aS,1S)-
  • CS-0028206
  • NS00068750
  • C09621
  • G13201
  • (S)-6-Methyl-2-((S)-4-methylcyclohex-3-en-1-yl)hept-5-en-2-ol
  • EN300-19632355
  • Q179896
  • A1201883
  • (-)-alpha-BISABOLOL (CONSTITUENT OF CHAMOMILE)
  • 3-Cyclohexene-1-methanol, alpha,4-dimethyl-alpha-(4-methyl-3-pentenyl)-, (alphaS,1S)-
  • BRD-K62751771-001-01-3
  • ((-))-6-Methyl-2-(4-methyl-3-cyclohexen-1-yl)-5-hepten-2-ol
  • 5-Hepten-2-ol, 6-methyl-2-(4-methyl-3-cyclohexen-1-yl)-, (-)-
  • 6-Methyl-2-(4-methyl-3-cyclohexen-1-yl)-5-hepten-2-ol
  • B1370-273703
  • (-)-alpha-Bisabolol, primary pharmaceutical reference standard
  • 515-69-5
  • Levomenol, United States Pharmacopeia (USP) Reference Standard
  • (-)-.ALPHA.-BISABOLOL (CONSTITUENT OF CHAMOMILE) [DSC]
  • (2S)-2-[(1S)-4-Methyl-3-cyclohexenyl]-6-methyl-5-heptene-2-ol
  • (S)-6-Methyl-2-[(S)-4-methyl-3-cyclohexenyl]-5-heptene-2-ol
  • 3-Cyclohexene-1-methanol, .alpha.,4-dimethyl-.alpha.-(4-methyl-3-pentenyl)-, [S-(R*,R*)]-
  • 3-Cyclohexene-1-methanol, alpha,4-dimethyl-alpha-(4-methyl-3-pentenyl)-, (S-(theta,theta))-
  • 6-Methyl-2-(4-methyl-3-cyclohexen-1-yl)-5-hepten-2-ol, (-)-
  • (?)-6-Methyl-2-(4-methyl-3-cyclohexen-1-yl)-5-hepten-2-ol,Levomenol
  • 3-Cyclohexene-1-methanol, ?,4-dimethyl-?-(4-methyl-3-pentenyl)-, (R,R)-
  • 5-HEPTEN-2-OL, 6-METHYL-2-(4- METHYL-3-CYCLOHEXEN-1-YL), (-)-
  • 5-HEPTEN-2-OL, 6-METHYL-2-(4-METHYL-3-CYCLOHEXEN-1-YL), (-)-
  • alpha,4-Dimethyl-alpha-(4-methyl-3-pentenyl)-3-cyclohexene-1-methanol
  • (alpha R,1R)-rel-alpha,4-Dimethyl-alpha-(4-methyl-3-penten-1-yl)-3-cyclohexene-1-methanol
  • (R*, R*)- a, 4- dimethyl- a- (4- methyl- 3- pentenyl)cyclohex- 3- ene- 1- methanol
  • (R*,R*)-alpha,4-Dimethyl-alpha-(4-methyl-3-pentenyl)cyclohex-3-ene-1-methanol
  • [1S,alphaS,(-)]-alpha,4-Dimethyl-alpha-(4-methyl-3-pentenyl)-3-cyclohexene-1-methanol
  • [S-(R*,R*)]-.alpha.,4-Dimethyl-.alpha.-(4-methyl-3-pentenyl)cyclohex-3-ene-1-methanol
  • 3-ciclohexeno-1-metanol, ?,4-dimetil-?-(4-metil-3-penten-1-il)-, (?s,1s)-
  • 3-Cyclohexene-1-methanol, .alpha.,4-dimethyl-.alpha.-(4-methyl-3-pentenyl)-, (-)-
  • 3-Cyclohexene-1-methanol, .alpha.,4-dimethyl-.alpha.-(4-methyl-3-pentenyl)-, (R*,R*)-
  • 3-Cyclohexene-1-methanol, ?,4-dimethyl-?-(4-methyl-3-pentenyl)-, [S-(R,R)]-
  • 3-Cyclohexene-1-methanol, alpha,4-dimethyl-alpha-(4-methyl-3-pentenyl)-, (.alpha.S,1S)-
  • 3-Cyclohexene-1-methanol, alpha,4-dimethyl-alpha-(4-methyl-3-pentenyl)-, (S-(R*,R*))-
  • alpha,4-Dimethyl-alpha-(4-methyl-3-penten-1-yl)-(alphaS,1S)-3-Cyclohexene-1-methanol
  • (R*,R*) - a,4 - dimethyl - a - (4 - methyl - 3 - pentenyl)cyclohex - 3 - ene - 1 - methanol
  • 245-423-3
  • 3-ciclohexeno-1-metanol, Alfa,4-Dimetil-Alfa-(4-metil-3-penten-1-il)-, (Alfa R, 1R)-rel-
  • 3-CYCLOHEXENE-1-METHANOL, .ALPHA.,4-DIMETHYL-.ALPHA.-(4-METHYL-3-PENTEN-1-YL)-, (.ALPHA.S,1S)-
  • 3-Cyclohexene-1-methanol, .alpha.,4-dimethyl-.alpha.-(4-methyl-3-pentenyl)-, (.alpha.R,1R)-rel-
  • 3-Cyclohexene-1-methanol, ?,4-dimethyl-?-(4-methyl-3-penten-1-yl)-, (?R,1R)-rel-; 3-Cyclohexene-1-methanol, ?,4-dimethyl-?-(4-methyl-3-pentenyl)-, (R*,R*)-; 3-Cyclohexene-1-methanol, ?,4-dimethyl-?-(4-methyl-3-pentenyl)-, (?R,1R)-rel- (9CI); 5-Hepten-2-ol, 6-methyl-2-(4-methyl-3-cyclohexen-1-yl)- (6CI,7CI,8CI); rel-(?R,1R)-?,4-Dimethyl-?-(4-methyl-3-penten-1-yl)-3-cyclohexene-1-methanol; (+/-)-?-Bisabolol; Bisabolol; Camilol; Dragosantol; Dragosantol 100; Hydagen B; dl-?-Bisabolol; ?-Bisabolol
  • 3-Cyclohexene-1-methanol, a,4-dimethyl-a-(4-methyl-3-penten-1-yl)-, (aR,1R)-rel-; 3-Cyclohexene-1-methanol, a,4-dimethyl-a-(4-methyl-3-pentenyl)-, (R*,R*)-; 3-Cyclohexene-1-methanol, a,4-dimethyl-a-(4-methyl-3-pentenyl)-, (aR,1R)-rel- (9CI); 5-Hepten-2-ol, 6-methyl-2-(4-methyl-3-cyclohexen-1-yl)- (6CI,7CI,8CI); rel-(aR,1R)-a,4-Dimethyl-a-(4-methyl-3-penten-1-yl)-3-cyclohexene-1-methanol; (+/-)-a-Bisabolol; Bisabolol; Camilol; Dragosantol; Dragosantol 100; Hydagen B; dl-a-Bisabolol; a-Bisabolol
  • 3-CYCLOHEXENE-1-METHANOL, alpha,4-DIMETHYL-alpha-(4-METHYL-3-PENTEN-1-YL)-, (alphaS,1S)-